Applications published 6 June 2007

Therapeutic foam
BTG International 1791519*

Controlled release nanoparticle active agent formulation dosage forms and methods
Alza Corp 1791520*

Methods of administering water-soluble forms of propofol
Guildford Pharmaceuticals 1791521*

Dermally applicable formulations for treating skin diseases in animals
Bayer HealthCare 1791522*

Viscoelastic solution or gel formulation and methods of treating a body site with the same
Advanced Medical Optics 1791523*

Pharmaceutical compsn comprising a solid dispersion with a polymer matrix containing a continuous polydextrose phase of a polymer other than polydextrose
Sanofi-Aventis 1791524*

Liposomal compsns of glucocorticoid and glucocorticoid derivatives
Yissum Research Development Company of the Hebrew University of Jerusalem 1791525*

Pharmaceutical multiparticulate compsn comprising mycophenolic acid or mycophenolate sodium and combination compsns with rapamycin
Novartis 1791526*

Coating compsn
FMC Corp 1791527*

Lyophilisate containing N-diamino-methylene-2-methyl-4,5-di-(methyl-sulphonyl)-benzamide
Merck Patent 1791528*

P277 peptide formulations or variants thereof having optimised stability
Sanofi-Aventis Deutschland 1791529*

Psychostimulant containing pharmaceutical compsn
PEJO Iserlohn Heitmittel-und Diaet 1791530*

Paroxetine formulations
Alpharma 1791532*

Compsn in micro-pellets with controlled release of physiologically active substances, procedure for their preparation and use in the zootechnical sector
Ascor Chimici 1791532*

Transdermal therapeutic system comprising an adhesive layer method for siliconising the back layer of the system and use of said back layer
LTS Lohmann Therapie-Systeme 1791533*

Pharmaceutical compsn comprising the isomer of a betamimetic agent and an anti-cholinergic
Cipla 1791534*

Novel tellurium compounds and their use as immunomodulators
BioMAS 1791535*

1-[(3R)-amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2R)-carboxylic acid-benzyl amine derivatives and related compounds as dipeptidyl-peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes mellitus
Santhera Pharmaceuticals (Schweiz) 1791536*

3-arylthioindole-2-carboxamide derivatives and analogues thereof as inhibitors of casein kinase I
Aventis Pharmaceuticals 1791537*

Roflumilast and SYK inhibitor combination and methods of use thereof
Altana Pharma 1791538*

Process to prepare camptothecin derivatives
Chatham Biotec 1791539*

Methods of treating cognitive disorders using pyridyloxymethyl and benzisoxazole azabicyclic derivatives
Pfizer Products 1791540*

Methods of treating mood disorders using benzisoxazole containing diazabicyclic compounds
Pfizer Products 1791541*

Diketopiperazine salts, diketodioxane salts for drug delivery
Mannkind Corp 1791542*

Triazolophthalazines
Altana Pharma 1791543*

Quinazoline derivatives as metabolically inert antifolate compounds
Chelsea Therapeutics 1791544*

Prostaglandin derivatives for treating gastrointestinal disorder
Sucampo 1791545*

Long acting injectable crystal formulations of estradiol metabolites and methods of using same
PR Pharmaceuticals 1791546*

Oral formulations of paricalcitol
Abbott Laboratories 1791547*

Compsn and methods for smoking cessation
Modus Biological Membranes 1791548*

Sulphonylethyl phosphorodiamidates for use in the treatment of cancer
Telik 1791549*

Use of ATP for the manufacture of a medicament for the prevention and treatment of oxidative stress and related conditions
Universiteit van Maastricht 1791550*

Method and device for diagnosing and treating insulin-like growth factor deficiency disorders
Tercica 1791551*

Protein A compsns and methods of use
Protalex 1791552*

Compsns for delivering peptide YY and PYY agonists
Emisphere Technologies 1791553*

Pharmaceutical compsns containing insulin and insulintropic peptide
Novo Nordisk 1791554*

Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis
Pharmaorigin 1791555*

Modified HIV-1 envelope proteins
The Henry M Jackson Foundation; Institute of Tropical Medicine 1791556*

Aptamer medicinal chemistry
Archemix 1791557*

Vaccines comprising plasmodium antigens
GlaxoSmithKline Biologicals 1791558*

Immunogenic compsn
GlaxoSmithKline Biologicals 1791559*

Polypeptides for inducing a protective immune response against Staphylococcus aureus
Merck 1791560*

Haemorrhagic feline calcivirus, calcivirus vaccine and method for preventing calcivirus infection disease
Wyeth 1791561*

Multivalent meningococcal derivatised polysaccharide-protein conjugates and vaccine
Sanofi Pasteur 1791562*

Anti-CD154 antibodies
Biogen Idec 1791563*

Drying process for preserving an active agent as a highly viscous liquid
GlaxoSmithKline Biologicals 1791564*

Cysteine engineered antibodies and conjugates
Genentech 1791565*

Product and process for inhibition of biofilm development
National Jewish Medical and Research Centre 1791566*

Chemically modified oligonucleotides
Alnylam Pharmaceuticals 1791567*

Therapeutic uses of inhibitors of RTP801
Quark Biotech 1791568*

Improved selection of Ph-dependent compounds for in vivo therapy
Emory University 1791569*

Superparamagnetic gadolinium oxide nanoscale particles and compsns comprising such particles
Optoqrit 1791570*

Radiofluorinated peptides
GE Healthcare AS; GE Healthcare Ltd 1791571*

Method of activating prions
Ecolab 1791572*

Carbonyl compound-containing drug and the use thereof
Merck Patent 1791597*

Use of metronidazole combined with azelic acid for the treatment of rosacea
Galderma Research & Development 1791598*

Combination of a 5HT(1) receptor agonist and an alpha-2-delta ligand for the treatment of migraine
Pfizer 1791599*

Combination of organic compounds
Novartis; Novartis-Pharma 1791600*

Novel vaccine for veterinary and human medicine prophylaxis and therapy
Riemer Arzneimittel; Bioveta 1791601*

4-aminomethyl benzamidine derivatives and their use as factor VIIA inhibitors
F Hoffmann-La Roche 1791810*

Aminoalcohol derivatives
Astellas Pharma 1791811*

4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogues
Janssen Pharmaceutica 1791812*

Pentafluorosulphanylphenyl-substituted benzoylguanidines, method for the production thereof, their use as a medicament or diagnostic agent, and a medicament containing these compounds
Sanofi-Aventis Deutschland 1791813*

Ortho-substituted pentafluorosulphanyl benzenes, method for the production thereof and their use as synthesis intermediates
Sanofi-Aventis Deutschland 1791814*

Pyrrolidine derivatives acting as CCR3-receptor antagonists
Novartis 1791815*

Iodine-phenyl-substituted cyclic cetoenols
Bayer CropScience 1791816*

DPP-IV inhibitors
Santhera Pharmaceuticals 1791817*

Hydrazone derivatives and their use as beta secretase inhibitors
The Genetics Company 1791818*

(Hetero)cyclo(thio)carboxylic acid anilides for controlling pathogenic fungi
BASF 1791819*

Enantioselective preparation of quinoline derivatives
Novartis 1791820*

Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS)
Janssen Pharmaceutica 1791821*

Substituted N0-acyl-2-aminothiazoles
F Hoffmann-La Roche 1791822*

Antibiotic and method for production thereof
Helmholtz-Zentrum fuer Infektionsforschung 1791823*

Benzoyl-substituted serine amides
BASF 1791825*

Crystalline polymorph of pipendoxifene hydrochloride monohydrate
Wyeth 1791826*

4-heteroarylmethyl substituted phthalazinone derivatives
Kudos Pharmaceuticals 1791827*

Process for preparing N-(substituted arylmethyl)-4-substituted-4-(disubstituted methyl) piperidines and intermediates
Bayer CropScience 1791828*

Diaminotriazole compounds useful as protein kinase inhibitors
Vertex Pharmaceuticals 1791830*

Methods of treating diseases and disorders by targeting multiple kinases
Signal Pharmaceuticals 1791831*

4-(heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
Allergan 1791832*

4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
Allergan 1791833*

5-heterocyclic pyrimidines
Bayer CropSciences 1791834*

Thiazole derivatives having VAP-1 inhibitory activity
Astellas Pharma 1791835*

Thiazolinone-2-substituted quinolines
F Hoffmann-La Roche 1791836*

Substituted hydantoins for the treatment of cancer
F Hoffmann-La Roche 1791837*

Process for preparing substituted 8-azabicyclo[3.2.1]octan-3-ols
Schering-Plough 1791838*

Preparation of 9-hydroxy-3-(2-hydroxyethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-ones and crystals thereof
Janssen Pharmaceutica 1791839*

Substituted bicyclic imidazo-3-ylamine compounds
Gruenenthal 1791840*

2-substituted-1-deaza purine derivatives with adenosine receptor modulating activity
Solvay Pharmaceuticals 1791841*

Process for the preparation of 6,8-substituted 1,7-naphthpyridin derivatives by reacting the 8-halo-1,7 naphthpyridin-derivative with an organic boronic acid derivatives and intermediates of this process
Novartis; Novartis-Pharma 1791842*

Monocyclic anilide spirolactam CGRP receptor antagonists
Merck 1791843*

8-(3-amino-piperidin-1-yl)-7-(but-2-inyl)-xanthines, production thereof and use thereof as medicaments
Boehringer Ingelheim 1791844*

Furanopyridine derivatives as ACK1 and LCK modulators
Amgen 1791845*

An improved process for the preparation of irinotecan hydrochloride trihydrate
Shilpa Medicare 1791846*

Novel 3-tia-10-aza-phenanthrene derivatives
Altana Pharma 1791847*

Process for the production of (trimethylsiloxy)silylalkylglycerol methacrylates
Johnson and Johnson Vision Care 1791848*